Fulltext
A six year old male child with normal developmental history presented with bilateral breast engorgement since six months with no history suggestive of development of secondary sexual characters. His body mass index was 17.28 (>85th centile) with no mass palpable on per abdominal examination. SMR for testes, pubic hair and penis was prepubescent and breast maturity scale corresponded to stage 3 thelarche (Fig. 1A). Blood pressure, visual field and other systems were normal. His bone age was 12 years. Hemogram, liver and renal functions were normal. Contrast enhanced computed tomogram of abdomen showed well defined hypodense non-homogenous contrast enhanced right sided adrenal mass without calcification or fat density within. Well defined plane at upper pole of kidney was delineated. Blood vessels were normal (Fig. 2). Hormonal assay showed normal levels of serum FSH, LH, cortisol and testosterone with elevated levels of estradiol (28.94 pg/ml, ref range <10) and 17(OH)progesterone (2.2ng/ml, ref range <1.5) suggesting feminization. Tumor was resected by laparoscopy. Gross adrenal mass was partially capsulated measuring 4×3.5×2.5 cms, weighing 30gms with congested blood vessels and hemorrhagic areas on cut section. Histopathology showed tumor cells with pleomorphic nuclei with irregularly distributed coarse chromatin with >one mitotic figure/10 hpf. Capsule and vascular

Fig. 1A & B: Clinical photograph of gynecomastia before (left) and after (right) surgery

Fig. 2: Computed tomogram imaging of the abdomen showing right sided adrenal mass
invasion was noted in microscopic examination.
Though tumor size was less than five cm, it was classified as stage 3 based on UICC staging in view of micro metastasis. Post surgically, child required cortisole replacement for 48 hours. Chemotherapy was administered with cisplatin and etoposide in cycles at monthly intervals for six months. At one year follow-up, the serial hormonal assays are normal and gynecomastia is regressing (Fig. 1B). Adrenal neoplasm has unknown etiology but cytogenetic cloning studies have described characteristic chromosomal abnormalities[2]. Usual age of presentation is fourth decade and in childhood median age is three years with female predominance[3]. Feminization syndrome is rarely observed presentation and in a recent review, the prevalence of these tumors ranged from 1%-2%[4]. Estrogen and derivatives like estradiol, estrone are predominant hormones secreted, resulting in gynecomastia in males. Feminizing syndrome usually regresses after removal of tumor but rarely requires mammoplasty[4]. In the above case normalization of hormones in follow-up indicated successful resection of tumor not warranting any corrective surgery. Treatment of ACT consists of radical open surgery, en bloc resection of tumor, adjacent infiltrated organs and/or regional lymphadenectomy, however laparoscopic removal is possible in stage 1 and 2[2]. Decision for laparoscopic removal was based on imaging findings as it can be safely performed even in malignant forms of adrenal tumors[5]. Definite staging with detailed pathological classification is assessed after the surgery. Due to unavailability of mitotane in our country cisplatin and etoposide were used for chemotherapy. There are no well controlled studies to compare the benefit of mitotane and other drugs as first line therapy[6]. Adrenal suppression of the contralateral adrenal gland is seen during post-operative period requiring replacement therapy from days to weeks[3]. Large size of the tumor and invasion of the adjacent organs mark poorer prognosis. Recurrent symptoms or biochemical abnormalities should prompt a careful search for metastatic disease.
Functional ACT of childhood is a rare entity and presents with rapid clinical course prompting an aggressive approach in diagnosis and management.